Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 903.78 Million HKD | -7.87% |
| 2022 | 981.03 Million HKD | -13.12% |
| 2021 | 1.12 Billion HKD | 13.47% |
| 2020 | 995.14 Million HKD | 12.98% |
| 2019 | 880.79 Million HKD | 69.13% |
| 2018 | 520.78 Million HKD | 23.91% |
| 2017 | 420.28 Million HKD | 11.65% |
| 2016 | 376.43 Million HKD | 68.33% |
| 2015 | 223.63 Million HKD | 30.02% |
| 2014 | 171.99 Million HKD | 29.3% |
| 2013 | 133.01 Million HKD | -1.81% |
| 2012 | 135.47 Million HKD | 147.94% |
| 2011 | 54.63 Million HKD | 48.18% |
| 2010 | 36.87 Million HKD | 64.18% |
| 2009 | 22.45 Million HKD | -68.89% |
| 2008 | 72.19 Million HKD | 21.89% |
| 2007 | 59.23 Million HKD | 161.7% |
| 2006 | 22.63 Million HKD | 71.0% |
| 2005 | 13.23 Million HKD | 34.95% |
| 2004 | 9.8 Million HKD | -12.11% |
| 2003 | 11.15 Million HKD | -42.85% |
| 2002 | 19.52 Million HKD | 157.67% |
| 2001 | 7.57 Million HKD | -65.05% |
| 2000 | 21.68 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 950.32 Million HKD | 0.0% |
| 2023 FY | 903.78 Million HKD | -7.87% |
| 2023 Q2 | 1.02 Billion HKD | 0.0% |
| 2023 Q4 | 903.78 Million HKD | 0.0% |
| 2022 Q2 | 1.05 Billion HKD | 0.0% |
| 2022 FY | 981.03 Million HKD | -13.12% |
| 2022 Q4 | 981.03 Million HKD | 0.0% |
| 2021 Q2 | 1.04 Billion HKD | 0.0% |
| 2021 Q4 | 1.12 Billion HKD | 0.0% |
| 2021 FY | 1.12 Billion HKD | 13.47% |
| 2020 Q2 | 686.33 Million HKD | 0.0% |
| 2020 FY | 995.14 Million HKD | 12.98% |
| 2020 Q4 | 995.14 Million HKD | 0.0% |
| 2019 Q4 | 880.79 Million HKD | 0.0% |
| 2019 Q2 | 591.13 Million HKD | 0.0% |
| 2019 FY | 880.79 Million HKD | 69.13% |
| 2018 Q2 | 531.15 Million HKD | 0.0% |
| 2018 Q4 | 520.78 Million HKD | 0.0% |
| 2018 FY | 520.78 Million HKD | 23.91% |
| 2017 FY | 420.28 Million HKD | 11.65% |
| 2017 Q2 | 431.6 Million HKD | 0.0% |
| 2017 Q4 | 420.28 Million HKD | 0.0% |
| 2016 Q4 | 376.43 Million HKD | 0.0% |
| 2016 Q2 | 371.15 Million HKD | 0.0% |
| 2016 FY | 376.43 Million HKD | 68.33% |
| 2015 Q4 | 223.63 Million HKD | 0.0% |
| 2015 Q2 | 178.67 Million HKD | 0.0% |
| 2015 FY | 223.63 Million HKD | 30.02% |
| 2014 Q2 | 166.54 Million HKD | 0.0% |
| 2014 Q4 | 171.99 Million HKD | 0.0% |
| 2014 FY | 171.99 Million HKD | 29.3% |
| 2013 Q4 | 133.01 Million HKD | 0.0% |
| 2013 FY | 133.01 Million HKD | -1.81% |
| 2013 Q2 | 151.96 Million HKD | 0.0% |
| 2012 Q4 | 135.47 Million HKD | 0.0% |
| 2012 FY | 135.47 Million HKD | 147.94% |
| 2012 Q2 | 101.79 Million HKD | 0.0% |
| 2011 FY | 54.63 Million HKD | 48.18% |
| 2011 Q4 | 54.63 Million HKD | 0.0% |
| 2011 Q2 | 40.78 Million HKD | 0.0% |
| 2010 Q2 | 24.39 Million HKD | 0.0% |
| 2010 FY | 36.87 Million HKD | 64.18% |
| 2009 FY | 22.45 Million HKD | -68.89% |
| 2008 FY | 72.19 Million HKD | 21.89% |
| 2007 FY | 59.23 Million HKD | 161.7% |
| 2006 FY | 22.63 Million HKD | 71.0% |
| 2005 FY | 13.23 Million HKD | 34.95% |
| 2004 FY | 9.8 Million HKD | -12.11% |
| 2003 FY | 11.15 Million HKD | -42.85% |
| 2002 FY | 19.52 Million HKD | 157.67% |
| 2001 FY | 7.57 Million HKD | -65.05% |
| 2000 FY | 21.68 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -535.204% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | 87.525% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -430.366% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -27.355% |
| Qianhai Health Holdings Limited | 94 Million HKD | -861.439% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | 2.826% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -35.828% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -31.049% |
| SSY Group Limited | 4.49 Billion HKD | 79.889% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -146.428% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | 17.122% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 99.464% |